A fetus in the uterus is not rejected at any time during the entire gestational period, even without the administration of immunosuppressive agents, though fetus is a kind of allograft. This prevention of rejection is considered to be associated with the presence of placental tissues. This hypothesis was tested by the allografting of islets together with placental tissues (trophoblasts) in streptozotocin (STZ)-induced diabetic mice. Placentae were harvested from the mice at the 14th postgestation day by being peeled off carefully and with the maternal decidua left behind, and cut into small pieces. Five hundred freshly isolated islets together with placental tissues obtained from ICR mice were placed under the left kidney capsule of STZinduced diabetic C57BL/6J mice. The nonfasting blood glucose level was reduced from 477 ± 41 mg/dl at the time of pretransplant to that of the intact normal mice (161 ± 18 mg/dl) soon after the cografting, and did not return to the pretransplant level before the 14th posttransplant day. The grafting of the same number of islets alone and/or liver tissues dropped the blood glucose level, but not to that of the intact normal mice. It returned to the pretransplant level within 1 week. This is the first successful prolongation of survival of allografted islets without immunosuppressive agents through cotransplantation of allogenic placental tissues. The underlying mechanism remains to be clarified.
INTRODUCTION
C57BL/6J mice aged 8 weeks were made diabetic with streptozotocin (180 mg/kg, IP; Sigma Chemical Co., St. The fetus is a kind of allograft, but it stays in the Louis, MO) at least 1 week prior to transplantation. uterus without rejection throughout the entire period of Those with nonfasting blood glucose (NFBG) of over gestation, even though immunosuppressive agents are 350 mg/dl were selected as recipients. Islets isolated not administered, as in case of allogeneic transplantation from male ICR and C57BL/6J mice aged 8-16 weeks of organs and/or tissues. This phenomenon appears to be by a modification of the method of Gotoh et al. (6,10explained by the presence of the placental tissue, which 12) were used as donors of islets. After purification on blocks direct contact between the blood cells of the fetus a gradient of Histopaque  -1077 (Sigma Chemical Co.), and its host (13). The location of the trophoblast in the islets with a diameter between 75 and 250 µm were placenta at the boundary between the fetus and its host handpicked for transplantation. Placentae and livers may explain the prevention of fetal rejection induced by were removed and collected from female ICR mice at the host immune system (2,5,7,8). Because the trophothe 14th postgestation day. They were cut into small blast may also possess some other unknown functions, pieces for cotransplantation with islets. the present study on cografting allogeneic islets with Islets and/or either placental tissues or liver tissues placental tissue was carried out without the administrawere transplanted under the left renal capsule of diabetic tion of immunosuppressive agents to confirm the prolonmice within 1-4 weeks after STZ treatment. They congation of survival of grafted islets. sisted of group I mice with grafting of only placental MATERIALS AND METHODS tissues of ICR mice, group II with that of 500 alloislets if ICR mice, group III with that of 500 alloislets and ICR and C57BL/6J mice were purchased from Nippon SLC Laboratories (Hamamatsu, Japan). Male liver tissues of ICR mice, group IV with that of 500 456 SUZUKI ET AL.
alloislets and placental tissues of ICR mice, and group DISCUSSION V with 500 isoislets of C57BL/6J mice. No immunosup-This is the first achievement of prolongation of surpressive agents were used throughout the observation vival of allotransplanted islets without the administraperiod in this study. NFBG in the blood obtained by tail tion of immunosuppressive agents through cografting of snipping at day 0 (before transplantation) and days 3, 7, allogenic placental tissues, though the period of normo-10, 14, 21, and 28 posttransplant were measured with a glycemia obtained was not satisfactory. portable glucometer (Glutest-ace  , Sanwakagaku, Na-
The mechanism of this prolonged survival remains to goya, Japan). NFBG levels of nontransplanted diabetic be clarified. Because of its location at the maternal-fetal mice and normal intact mice were also followed up for interface, the trophoblast is thought to serve as a barrier 4 weeks in groups VI and VII, respectively.
by shielding the fetus from maternal effector cells (1,7).
Histological examination with hematoxylene staining
The syncytiotrophoblast expresses neither HLA class I was conducted at day 14 posttransplant in group IV.
nor class II antigens in humans (4, 9) . The placental extravillous cytotrophoblast, which is exposed to the ma-RESULTS ternal uterine decidua and blood, expresses nonclassical HLA-G (3,7). No allelic variation is detected in humans NFBG in group IV was reduced from 477 ± 41 mg/ dl (mean ± SE) pretransplant to the normal range (161 ± (7). These considerations, together with no fetal rejection during the period of pregnancy, indicate that the 18 mg/dl) by day 3 after simultaneous grafting of islets and placental tissues, and did not return to the pretrans-expression of HLA-G may act to protect the cytotrophoblast from destruction induced by maternal NK cells (9). plant level before day 14 posttransplant. The NFBG of the diabetic mice in groups II and III was not normalized
The presence of a similar underlying mechanism may explain the present successful observation of prolonga-after the grafting. That of the diabetic mice in group I was similar to that in group VI. NFBG in group V mice tion of allografted islets without simultaneous administration of immunosuppressive agents even in rodents. was reduced to the normal level by day 3 posttransplant, and remained within the NFBG range obtained in group
The increase in normalized blood glucose by 2 weeks posttransplant is seemingly due to the disappearance of VII mice for the whole observation period (Fig. 1) .
Placental tissues were not detected under the renal the cografted placental tissues, which might have prevented the rejection of allogeneic tissues. capsule 2 weeks after transplantation (Fig. 2) . 
